FDA Approves Gilead’s Bixlenvo for HIV Treatment
Foster City, California, August 27, 2026 Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has...
HIV-1
Advertisement
ViiV Healthcare’s Tivicay PD Wins FDA Approval for Kids
LONDON, Aug 26, 2026 The U.S. Food and Drug Administration (FDA) has approved Tivicay PD (dolutegravir) from ViiV Healthcare...
ViiV Healthcare Reports Positive Phase IIIb Dovato Results
London, July 27, 2026 ViiV Healthcare has announced positive Week 48 results from the Phase IIIb VOGUE study, demonstrating...
TaiMed Receives TFDA Notice for Trogarzo
TAIPEI, Taiwan, July 8, 2026 TaiMed Biologics announced that it has received a Drug License Collection Notice from the...
Advertisement
